2025-10-17 - Analysis Report
Okay, here's an analysis of Albemarle Corp (ALB) based on the data provided. I'll present the information in a structured manner, with a summary at the end.

## Albemarle Corp (ALB) Analysis

Albemarle Corp is a global specialty chemicals company with leading positions in lithium, bromine, and catalysts.

### 1. Performance vs. S&P 500 (VOO)

*   **Cumulative Return (ALB):** -7.10%
*   **Cumulative Return (VOO):** 96.43%
*   **Absolute Divergence:** -112.4
*   **Relative Divergence:** 2.6 (On a scale where the min-max range of divergence is 100, the current divergence is at the 2.6th percentile)

**Analysis:** ALB has significantly underperformed the S&P 500. The relative divergence suggests that ALB's underperformance is near the lower end of its historical range compared to VOO.

### Alpha, Beta Analysis

| Year       | CAGR     | MDD     | Alpha   | Beta   | Cap(B) |
| :--------- | :------- | :------ | :------ | :----- | :------ |
| 2015-2017  | 85.0%    | 68.0%   | 56.0%   | 0.1    | 14.9   |
| 2016-2018  | 9.0%     | 68.0%   | -6.0%   | 0.0    | 9.0    |
| 2017-2019  | -44.0%   | 73.9%   | -66.0%  | 0.1    | 8.5    |
| 2018-2020  | 44.0%    | 79.4%   | 20.0%   | 0.2    | 17.2   |
| 2019-2021  | 149.0%   | 79.4%   | 103.0%  | -0.1   | 27.2   |
| 2020-2022  | 148.0%   | 79.9%   | 149.0%  | 0.5    | 25.3   |
| 2021-2023  | -26.0%   | 81.9%   | -27.0%  | 0.5    | 16.8   |
| 2022-2024  | -152.0%  | 81.9%   | -172.0% | 0.3    | 10.0   |
| 2023-2025  | -228.0%  | 81.9%   | -289.0% | -0.4   | 11.2   |

**Analysis:**

*   **CAGR & MDD:** Albemarle has exhibited wide swings in performance (CAGR) over different periods, with significant drawdowns (MDD). The recent periods (2021-2025) show negative CAGR and high MDD, indicating substantial losses and volatility.
*   **Alpha:** Alpha measures the excess return of an investment relative to a benchmark. The negative alpha values in recent years highlight ALB's underperformance compared to its benchmark.
*   **Beta:** Beta measures the volatility of an investment relative to the market. ALB's beta values have fluctuated, suggesting varying degrees of correlation with market movements. More recently, the negative Beta indicates a negative correlation.
*   **Cap(B):** Shows Market Cap in Billions

### 2. Recent Price Action

*   **Current Price:** 96.24
*   **Last Market Data:** Price: 95.29, Previous Close: 98.16, Change: -2.92
*   **5-Day Moving Average:** 92.79
*   **20-Day Moving Average:** 86.31
*   **60-Day Moving Average:** 80.76

**Analysis:** ALB is trading above its 5, 20, and 60-day moving averages, suggesting a short-term upward trend. However, the recent price change (-2.92) from the previous close indicates a slight pullback.

### 3. Technical Indicators

*   **MRI (Market Risk Indicator):** 0.8 (Medium Investment Recommended)
*   **RSI (Relative Strength Index):** 69.92 (Approaching Overbought)
*   **PPO (Percentage Price Oscillator):** 1.02
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (12 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-10-01)
*   **Recent (20-day) Relative Divergence Change:** 0.5 (Short-term increase)
*   **Expected Return:** 1238.0% (Long-term, relative to S&P 500)

**Analysis:**

*   The MRI suggests a medium investment recommendation, balancing risk and potential return.
*   The RSI is approaching overbought territory, which could signal a potential pullback.
*   The PPO indicates that the short-term moving average is above the long-term moving average, supporting the recent upward trend.
*   The Hybrid Signal suggests a "Buy" signal.
*   The significant recent price drop from 98.16 to 95.29 reflects increased market volatility and concern, warranting caution.
*   The extremely high expected return (1238.0%) should be viewed with skepticism, as it represents a very optimistic long-term outlook relative to the S&P 500 and might be driven by specific model assumptions.

### 4. Recent News & Significant Events

*   **Trump Stock Market Bingo:** Potential impact on miners.
*   **Albemarle (ALB) Laps the Stock Market:** Positive news, indicating outperformance.
*   **Why Investors Need to Take Advantage of These 2 Basic Materials Stocks Now:** Positive sentiment towards basic materials.
*   **BofA Cuts Albemarle To Neutral:** Downgrade to neutral with a price target of $100.
*   **US Chemicals Sector Faces Commodity Oversupply, Weak Demand:** Negative industry outlook.
*   **Argus Research Adjusts Albemarle Price Target to $120 From $90:** Upgrade with increased price target.

**Analysis:** Recent news presents a mixed picture. While some articles suggest positive prospects for Albemarle and the basic materials sector, others highlight challenges like commodity oversupply and a downgrade from BofA. The conflicting analyst opinions underscore the uncertainty surrounding the stock.

### 4-2. Analyst Opinions

*   **Consensus:** Hold
*   **Mean Rating:** 2.72 (~Hold)
*   **Target Price (avg/high/low):** 89.60 / 200.00 / 58.00

**Analysis:** The analyst consensus is "Hold," reflecting a neutral outlook on the stock. The wide range in target prices (58.00 to 200.00) indicates significant disagreement among analysts regarding the potential future value of Albemarle.

### 5. Recent Earnings Analysis

| 날짜       | EPS    | 매출       |
| :--------- | :----- | :--------- |
| 2025-08-04 | -0.16  | 1.33 B$    |
| 2025-04-30 | 0      | 1.08 B$    |
| 2024-11-06 | -9.45  | 1.35 B$    |
| 2024-07-31 | -1.96  | 1.43 B$    |
| 2025-08-04 | -1.96  | 1.43 B$    |

**Analysis:** Recent earnings have been volatile, with negative EPS figures in most quarters. The revenue has also fluctuated, indicating potential challenges in the company's operations.

### 6. Financial Information

| Quarter    | Revenue   | Profit Margin |
| :--------- | :-------- | :------------ |
| 2025-06-30 | \$1.33B   | 14.80%        |
| 2025-03-31 | \$1.08B   | 14.51%        |
| 2024-12-31 | \$1.23B   | 11.22%        |
| 2024-09-30 | \$1.35B   | -7.68%        |
| 2024-06-30 | \$1.43B   | -0.74%        |

| Quarter    | Equity   | ROE       |
| :--------- | :------- | :-------- |
| 2025-06-30 | \$10.24B | 0.22%     |
| 2025-03-31 | \$10.03B | 0.41%     |
| 2024-12-31 | \$9.96B  | 0.76%     |
| 2024-09-30 | \$10.24B | -10.44%   |
| 2024-06-30 | \$11.22B | -1.68%    |

**Analysis:**

*   **Revenue and Profitability:** While recent revenue figures are still significant, the profit margin has fluctuated. Negative profit margins in some quarters raise concerns about the company's operational efficiency and cost management.
*   **Capital and Profitability:** Equity has remained relatively stable. However, the ROE (Return on Equity) has been volatile, with negative values in some periods, indicating that the company is not consistently generating profits from its equity.

### 7. Overall Summary

Albemarle (ALB) has significantly underperformed the S&P 500 recently. While the stock shows a short-term upward trend based on moving averages and the Hybrid Signal, the RSI is nearing overbought levels, suggesting a possible pullback. Analyst opinions are neutral, and the news flow is mixed, with both positive and negative headlines. The recent earnings and financial data reveal volatile revenue, fluctuating profit margins, and inconsistent ROE, raising concerns about the company's operational and financial performance.

The extremely high "expected return" should be treated with caution. The analysis suggests a HOLD strategy, pending more consistent positive signals from earnings, industry trends, and analyst outlook. The recent price drop of nearly 3% underscores the volatility and potential risks associated with the stock. Investors should closely monitor the company's performance and industry developments before making any investment decisions.
